IL6 and major depressive disorder: Meta-analyses indicate that peripheral cytokines (including interleukin (IL)-1β, IL-6, and tumour necrosis factor (TNF)-α) and hippocampal inflammation are increased in individuals with MDD [35–38], indicating inflammation as potential biomarker for MDD.